Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2023

Discontinued Operations [Abstract]

Schedule of Discontinued Operations

The following table presents results of discontinued operations (in thousands):

	Years ended December 31,
	2023			2022
Product revenue, net	$	(833	)	$	80,749
Cost of goods sold		—			15,640
Gross profit (loss)		(833	)		65,109
Operating expenses:
Selling and marketing		—			75,208
General and administrative		481			11,301
Research and development		—			4,942
Restructuring charges		—			6,180
Total operating expenses		481			97,631
Loss from discontinued operations		(1,314	)		(32,522	)
Other income (expense):
Gain on sale of vitaCare		—			143,384
Gain on ANNOVERA sale		—			62,031
Loss on the extinguishment of debt		—			(8,380	)
Interest expense and other financing costs		—			(36,065	)
Expense for accretion of Series A Preferred Stock		—			(16,973	)
Loss on disposal of assets		(1,150	)		—
Other expense, net		(115	)		—
Total other income (expense), net		(1,265	)		143,997
Loss before from income taxes		(2,579	)		111,475
Benefit (provision) for income taxes		—			(552	)
Net income (loss) from discontinued operations	$	(2,579	)	$	110,923

Schedule of Classes of Liabilities of Discontinued Operations

The following table presents the carrying amounts of the classes of assets and liabilities of discontinued operations (in thousands):

	As of December 31,
	2023		2022
Assets:
Current assets:
Accounts receivable	$	344	$	—
Total assets		344		—
Current liabilities:
Accounts payable	$	—	$	12,243
Accrued expenses and other current liabilities		3,694		13,588
Total liabilities	$	3,694	$	25,831